| 1.5 |
4.6 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.8 |
2.3 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 0.7 |
2.0 |
GO:0001803 |
antibody-dependent cellular cytotoxicity(GO:0001788) type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
| 0.6 |
1.9 |
GO:2000562 |
negative regulation of interferon-gamma secretion(GO:1902714) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.6 |
3.7 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.6 |
2.2 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.5 |
1.5 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.5 |
1.4 |
GO:0090187 |
zymogen granule exocytosis(GO:0070625) positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.4 |
1.3 |
GO:0010752 |
signal complex assembly(GO:0007172) regulation of cGMP-mediated signaling(GO:0010752) |
| 0.4 |
1.7 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.4 |
1.2 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 0.4 |
1.1 |
GO:2000977 |
regulation of forebrain neuron differentiation(GO:2000977) |
| 0.3 |
1.2 |
GO:0001907 |
killing by symbiont of host cells(GO:0001907) induction of programmed cell death(GO:0012502) disruption by symbiont of host cell(GO:0044004) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) apoptotic process involved in embryonic digit morphogenesis(GO:1902263) positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.3 |
0.9 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.3 |
1.8 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.3 |
1.1 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.3 |
0.8 |
GO:0006296 |
base-excision repair, AP site formation(GO:0006285) nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.3 |
1.1 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.3 |
0.8 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 0.3 |
0.8 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.2 |
0.9 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 0.2 |
0.9 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.2 |
1.5 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.2 |
0.6 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.2 |
0.6 |
GO:1900158 |
negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 0.2 |
0.6 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.2 |
0.2 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.2 |
0.8 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.2 |
1.2 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.2 |
0.5 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.2 |
0.5 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.2 |
0.9 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.2 |
0.7 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.2 |
0.7 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.2 |
0.6 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.2 |
1.1 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.2 |
0.5 |
GO:0039521 |
suppression by virus of host autophagy(GO:0039521) negative regulation of sphingolipid biosynthesis involved in cellular sphingolipid homeostasis(GO:0090157) |
| 0.1 |
0.9 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.1 |
2.5 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.1 |
1.3 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.1 |
0.1 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.1 |
0.6 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.1 |
4.3 |
GO:0009648 |
photoperiodism(GO:0009648) |
| 0.1 |
0.6 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 |
1.8 |
GO:0071281 |
ferrous iron transport(GO:0015684) cellular response to iron ion(GO:0071281) |
| 0.1 |
0.6 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.1 |
0.7 |
GO:0070253 |
somatostatin secretion(GO:0070253) |
| 0.1 |
0.2 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.1 |
0.7 |
GO:0007343 |
egg activation(GO:0007343) |
| 0.1 |
1.0 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 |
0.4 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.1 |
1.3 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.1 |
0.9 |
GO:0033004 |
negative regulation of mast cell activation(GO:0033004) |
| 0.1 |
0.4 |
GO:0007320 |
insemination(GO:0007320) |
| 0.1 |
0.5 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 |
0.7 |
GO:0046645 |
positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.1 |
0.3 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.1 |
0.4 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.1 |
0.2 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.1 |
0.5 |
GO:0032604 |
granulocyte macrophage colony-stimulating factor production(GO:0032604) regulation of granulocyte macrophage colony-stimulating factor production(GO:0032645) positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
| 0.1 |
0.5 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
0.6 |
GO:0002681 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.1 |
1.5 |
GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.1 |
0.3 |
GO:0097211 |
prolactin secretion(GO:0070459) response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.1 |
0.2 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.1 |
0.6 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 |
0.2 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.1 |
0.7 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.1 |
2.1 |
GO:0003016 |
respiratory system process(GO:0003016) |
| 0.1 |
0.7 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.1 |
0.2 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.1 |
0.8 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.1 |
0.2 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.1 |
0.3 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.1 |
0.6 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.1 |
0.5 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 0.1 |
0.3 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.1 |
1.1 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
0.3 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 |
0.7 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 |
0.5 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.0 |
0.2 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.2 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.0 |
0.5 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.0 |
1.1 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.0 |
1.1 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
1.1 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.0 |
0.8 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.0 |
0.9 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.0 |
0.2 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 |
0.1 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.0 |
0.6 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.0 |
0.2 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.0 |
0.2 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.0 |
0.4 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.0 |
0.3 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) mitotic DNA replication checkpoint(GO:0033314) |
| 0.0 |
0.8 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) |
| 0.0 |
1.3 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.3 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.0 |
1.1 |
GO:0034629 |
cellular protein complex localization(GO:0034629) |
| 0.0 |
0.2 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 |
0.3 |
GO:0032306 |
regulation of prostaglandin secretion(GO:0032306) |
| 0.0 |
0.1 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.0 |
0.1 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) |
| 0.0 |
0.2 |
GO:0010886 |
regulation of cholesterol storage(GO:0010885) positive regulation of cholesterol storage(GO:0010886) regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.0 |
0.4 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.1 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.0 |
0.4 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.0 |
1.5 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.0 |
0.1 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.0 |
0.4 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 |
0.1 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.0 |
0.4 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 |
1.8 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 |
0.3 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.0 |
0.3 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.6 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 |
0.2 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.0 |
0.1 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.0 |
0.4 |
GO:0043030 |
regulation of macrophage activation(GO:0043030) |
| 0.0 |
0.2 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 |
2.3 |
GO:0007601 |
visual perception(GO:0007601) |
| 0.0 |
0.2 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.0 |
0.6 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 |
0.4 |
GO:0007548 |
sex differentiation(GO:0007548) |
| 0.0 |
0.1 |
GO:0046013 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.0 |
0.1 |
GO:2001025 |
positive regulation of response to drug(GO:2001025) |
| 0.0 |
0.2 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 |
0.1 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.0 |
0.2 |
GO:1900181 |
negative regulation of protein localization to nucleus(GO:1900181) |
| 0.0 |
0.3 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.0 |
0.9 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
0.5 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
0.1 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.0 |
0.3 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.0 |
0.9 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.0 |
0.2 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
0.7 |
GO:0051591 |
response to cAMP(GO:0051591) |
| 0.0 |
0.1 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.0 |
0.2 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.0 |
0.1 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) |
| 0.0 |
0.6 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.0 |
0.2 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
2.2 |
GO:0007605 |
sensory perception of sound(GO:0007605) |
| 0.0 |
0.1 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.0 |
0.2 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.0 |
0.3 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.0 |
0.3 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.0 |
0.3 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.0 |
0.3 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.0 |
0.7 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) |
| 0.0 |
0.1 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.0 |
0.2 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
0.1 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.1 |
GO:1900364 |
negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.0 |
1.5 |
GO:0048515 |
spermatid differentiation(GO:0048515) |
| 0.0 |
0.6 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.0 |
0.3 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.0 |
0.7 |
GO:0009063 |
cellular amino acid catabolic process(GO:0009063) |
| 0.0 |
0.3 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.0 |
0.3 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.1 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 |
0.1 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.0 |
0.4 |
GO:0070206 |
protein trimerization(GO:0070206) |
